BioArk & New Mexico Venture Studios have established a strategic partnership to support startups in life sciences, medtech, and deep tech. This alliance facilitates access to infrastructure, expertise, and markets between US and European markets, accelerating international growth and collaboration.
From Argentina to Valais: biomanufacturing innovator gains global recognition ! Stämm, the biotechnology company pioneering next-generation biomanufacturing systems, has been named among the inaugural SOSV Deep Tech 100, a selection recognizing 100 trailblazing companies from over 800 ventures in the global SOSV portfolio.
Stämm Recognized in Inaugural SOSV Deep Tech 100 Read More »
Bioscibex, the biotech hardware startup newly established at BioArk in Monthey, has won the final stage of the Venture Kick program, receiving CHF 100,000 to accelerate the development of its next-generation single-use bioreactors. This follows the company’s entry earlier this month into the Top 100 Swiss Startups ranking at 81st place. Recognition of a promising
Bioscibex secures CHF 100,000 Venture Kick phase III award ! Read More »
Join BioArk and its partners, EPIC Monthey, MINTworld Visp & HES-SO Valais-Wallis for a fun and interactive mini-exhibition: “Explore, experiment & imagine! ” taking place at the Foire du Valais on Wednesday 1 October 2025.
Discover your future in life sciences at the Foire du Valais! Read More »
Apply before 8 February 2026, for a chance to pitch your project at the 11th BioInnovation Day 2026 in CHUV-Lausanne.
BioInnovation Day – Call for project Read More »
Starting this school year, all schools in the canton can benefit from free round-trip train tickets with SBB to visit MINTworld during the 2025/26 academic year.
Valais School Classes Travel Free to MINTworld Read More »
Discover our interview of Edouard Alphandéry, Alpha Onco Swiss’s founder – recently ranked one of the World’s Top 2% Scientists by Stanford University for the fifth consecutive year !
AlphaOnco: from fundamental research to clinical application Read More »
Start-up Bioscibex, which grew out of an EPFL research laboratory, is on a mission to transform the manufacture of biological medicines. Currently, the commercial-scale cell culture process involves seven complex, costly and contamination-prone steps. However, with its innovative bioreactor, Bioscibex reduces these steps to two, thereby minimising costs, contamination risks and errors. In development for almost a year, the technology aims to help the pharmaceutical industry move towards safer and more efficient production. The start-up has just moved into the BioArk site in Monthey, where it will benefit from a dynamic ecosystem to support its development.
Start-up Bioscibex has set up at BioArk in Monthey Read More »
Precise Health SA, a dynamic start-up from the Energypolis Campus in Sion and supported by The Ark Foundation, has received the Best Innovation Award at the recent Targeting Phage Therapy Congress in Berlin. This distinction underlines the company’s leadership in developing digital solutions for combating multidrug-resistant bacterial infections, a critical challenge in global healthcare.
Precise Health: AI-driven phage therapy platform awarded at International Conference Read More »
The Pitch Challenge 2025, organized by the School of Engineering (Haute Ecole d’Ingénierie) of HES-SO Valais-Wallis, will take place in both Visp and Monthey. This annual event gives bachelor’s and master’s students a stage to present their thesis projects to a public audience and a professional jury in just 120 seconds.
Pitch Challenge 2025 by the HEI Read More »
